These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18070176)

  • 1. Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.
    Hellwinkel OJ; Kedia M; Isbarn H; Budäus L; Friedrich MG
    BJU Int; 2008 Mar; 101(6):753-7. PubMed ID: 18070176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
    Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
    Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
    Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
    Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX6 methylation and ectopic expression in human tumor cells.
    Salem CE; Markl ID; Bender CM; Gonzales FA; Jones PA; Liang G
    Int J Cancer; 2000 Jul; 87(2):179-85. PubMed ID: 10861471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant PIK3CA amplification and RASSF1A or PAX6 hypermethylation predict worse survival in gastric cancer.
    Yang Q; Shao Y; Shi J; Qu Y; Wu K; Dang S; Shi B; Hou P
    Clin Biochem; 2014 Jan; 47(1-2):111-6. PubMed ID: 24505629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine induced CpG methylation of Pax6 binding motif in StAR promoter reduces the gene expression and cortisol production.
    Wang T; Chen M; Liu L; Cheng H; Yan YE; Feng YH; Wang H
    Toxicol Appl Pharmacol; 2011 Dec; 257(3):328-37. PubMed ID: 21971485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
    Kitchen MO; Bryan RT; Haworth KE; Emes RD; Luscombe C; Gommersall L; Cheng KK; Zeegers MP; James ND; Devall AJ; Fryer AA; Farrell WE
    PLoS One; 2015; 10(9):e0137003. PubMed ID: 26332997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
    Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
    Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
    Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G
    Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
    Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
    Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers.
    Ebert MP; Mooney SH; Tonnes-Priddy L; Lograsso J; Hoffmann J; Chen J; Röcken C; Schulz HU; Malfertheiner P; Lofton-Day C
    Neoplasia; 2005 Aug; 7(8):771-8. PubMed ID: 16207479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic variations in breast cancer progression to lymph node metastasis.
    Urrutia G; Laurito S; Marzese DM; Gago F; Orozco J; Tello O; Branham T; Campoy EM; Roqué M
    Clin Exp Metastasis; 2015 Feb; 32(2):99-110. PubMed ID: 25628026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pax6 is a key component of regulated glucagon secretion.
    Gosmain Y; Cheyssac C; Masson MH; Guérardel A; Poisson C; Philippe J
    Endocrinology; 2012 Sep; 153(9):4204-15. PubMed ID: 22778220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pax6 represses androgen receptor-mediated transactivation by inhibiting recruitment of the coactivator SPBP.
    Elvenes J; Thomassen EI; Johnsen SS; Kaino K; Sjøttem E; Johansen T
    PLoS One; 2011; 6(9):e24659. PubMed ID: 21935435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.
    Liang G; Robertson KD; Talmadge C; Sumegi J; Jones PA
    Cancer Res; 2000 Sep; 60(17):4907-12. PubMed ID: 10987305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.